FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

41339311000001100: Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Jan 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2039071000001111 Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2039081000001113 Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) Is a Carbocisteine 250mg/5ml oral solution sugar free true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) Has specific active ingredient Carbocisteine true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) 300 ml Has AMP True Carbocisteine 250mg/5ml oral solution sugar free (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start